AU Patent

AU2006311544A1 — Pharmaceutical salts and polymorphs of N- (5-CHLORO-2-PYRIDINYL) -2- [ [4- [ (DIMETHYLAMINO) IMINOMETHYL] BENZOYL] AMINO] -5-METH OXY-BENZAMIDE, a factor XA inhibitor

Assigned to Millennium Pharmaceuticals Inc · Expires 2007-05-18 · 19y expired

What this patent protects

Patent listed against Bevyxxa.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006311544A1
Jurisdiction
AU
Classification
—
Expires
2007-05-18
Drug substance claim
No
Drug product claim
No
Assignee
Millennium Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.